Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

Carmel J Stock; Hiroe Sato; Carmen Fonseca; Winston A S Banya; Philip L Molyneaux; Huzaifa Adamali; Anne-Marie Russell; Christopher P Denton; David J Abraham; David M Hansell; Andrew G Nicholson; Toby M Maher; Athol U Wells; Gisela E Lindahl; Elisabetta A Renzoni

doi:10.1136/thoraxjnl-2012-201786

Article info

PDF

PDF +
Supplementary
Material

Interstitial lung disease

Original article

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

Free

Authors

Carmel J Stock Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK PubMed articles Google scholar articles
Hiroe Sato Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK PubMed articles Google scholar articles
Carmen Fonseca Centre for Rheumatology and Connective Tissue Diseases, University College London Medical School, London, UK PubMed articles Google scholar articles
Winston A S Banya Clinical Trials and Evaluation Unit, Royal Brompton and Harefield NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Philip L Molyneaux Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK PubMed articles Google scholar articles
Huzaifa Adamali Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK PubMed articles Google scholar articles
Anne-Marie Russell Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK PubMed articles Google scholar articles
Christopher P Denton Centre for Rheumatology and Connective Tissue Diseases, University College London Medical School, London, UK PubMed articles Google scholar articles
David J Abraham Centre for Rheumatology and Connective Tissue Diseases, University College London Medical School, London, UK PubMed articles Google scholar articles
David M Hansell Department of Radiology, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK PubMed articles Google scholar articles
Andrew G Nicholson Histopathology Department, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK PubMed articles Google scholar articles
Toby M Maher Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK PubMed articles Google scholar articles
Athol U Wells Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK PubMed articles Google scholar articles
Gisela E Lindahl Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK PubMed articles Google scholar articles
Elisabetta A Renzoni Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK PubMed articles Google scholar articles

Correspondence to Carmel Stock, Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, Emmanuel Kaye Building, 1B Manresa Road, London SW3 6LR, UK; c.stock{at}imperial.ac.uk

View Full Text

Citation

Stock CJ, Sato H, Fonseca C, et al

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

Thorax 2013;68:436-441.

Publication history

Received February 17, 2012
Revised November 21, 2012
Accepted December 20, 2012
First published January 15, 2013.

Online issue publication

September 01, 2022

Article Versions

Previous version (29 April 2016).
You are viewing the most recent version of this article.

Supplementary Data

This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Files in this Data Supplement:

Data supplement 1 - Online supplement

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Supplementary Data

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password